Evidence map›Paper›PMID 32733790›Full record

ArticleFrontiers in oncology2020

Single-Nucleotide Polymorphism Array Technique Generating Valuable Risk-Stratification Information for Patients With Myelodysplastic Syndromes.

Xia Xiao, Xiaoyuan He, Qing Li, Wei Zhang, Haibo Zhu, Weihong Yang, Yuming Li, Li Geng, Hui Liu, Lijuan Li and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Xia XiaoDepartment of Hematology, Tianjin First Central Hospital, Tianjin, China.
Xiaoyuan HeDepartment of Clinical Medicine, Nankai University School of Medicine, Tianjin, China.
Qing LiDepartment of Hematology, Tianjin First Central Hospital, Tianjin, China.
Wei ZhangDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
Haibo ZhuDepartment of Hematology, Tianjin First Central Hospital, Tianjin, China.
Weihong YangWuhan Kindstar Diagnostics Co./Kindstar Global Gene (Beijing) Technology, Inc., Wuhan, China.
Yuming LiDepartment of Hematology, Tianjin First Central Hospital, Tianjin, China.
Li GengDepartment of Hematology, Tianjin First Central Hospital, Tianjin, China.
Hui LiuDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
Lijuan LiDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
Huaquan WangDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
Rong FuDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
Mingfeng ZhaoDepartment of Hematology, Tianjin First Central Hospital, Tianjin, China.
Zhong ChenWuhan Kindstar Diagnostics Co./Kindstar Global Gene (Beijing) Technology, Inc., Wuhan, China.
Zonghong ShaoDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
Tianjin Medical University General Hospital · CNTianjin First Center Hospital · CNTianjin Medical University · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chromosome aberrationsidiopathic cytopenia of undetermined significance (ICUS)myelodysplastic syndrome (MDS)prognosissingle-nucleotide polymorphism (SNP)

Identifiers

PMID32733790
PMCPMC7358551
OpenAlexW3039531735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.